Cargando…

Identification of immune related molecular subtypes and prognosis model for predicting prognosis, drug resistance in cervical squamous cell carcinoma

Background: One of the features of tumor immunity is the immunosuppressive tumor microenvironment (TME). In this study, TME gene signatures were used to define the characteristics of Cervical squamous cell carcinoma (CESC) immune subtypes and construct a new prognostic model. Methods: Single sample...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Dongzhi, Zhang, Zijian, Zhang, Yongjing, Huang, Kangni, Li, Xiaoxue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063826/ https://www.ncbi.nlm.nih.gov/pubmed/37007965 http://dx.doi.org/10.3389/fgene.2023.1137995

Ejemplares similares

Prognosis comparison between small cell carcinoma of ovary and high-grade serous ovarian cancer: A retrospective observational cohort study
por: Hu, Dongzhi, et al.
Publicado: (2023)

Identification of immune subtypes of cervical squamous cell carcinoma predicting prognosis and immunotherapy responses
por: Li, Yimin, et al.
Publicado: (2021)

A Comprehensive RNA Expression Signature for Cervical Squamous Cell Carcinoma Prognosis
por: Xiong, Jie, et al.
Publicado: (2019)

Development of an Immune-Related Risk Signature for Predicting Prognosis in Lung Squamous Cell Carcinoma
por: Fu, Denggang, et al.
Publicado: (2020)

Identification of natural killer cell associated subtyping and gene signature to predict prognosis and drug sensitivity of lung adenocarcinoma
por: Zhang, Dexin, et al.
Publicado: (2023)

TGF-β Signaling Pathway-Based Model to Predict the Subtype and Prognosis of Head and Neck Squamous Cell Carcinoma
por: Zheng, Lian, et al.
Publicado: (2022)

A novel pyroptosis scoring model was associated with the prognosis and immune microenvironment of esophageal squamous cell carcinoma
por: Zhang, Zhan-Fei
Publicado: (2023)

Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development
por: Lu, Tong, et al.
Publicado: (2022)

Analysis of Immune–Stromal Score-Based Gene Signature and Molecular Subtypes in Osteosarcoma: Implications for Prognosis and Tumor Immune Microenvironment
por: Zheng, Dingzhao, et al.
Publicado: (2021)

Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients
por: Tan, Jun, et al.
Publicado: (2021)

Identification of a Ferroptosis Gene Set That Mediates the Prognosis of Squamous Cell Carcinoma of the Head and Neck
por: Li, Chunyan, et al.
Publicado: (2021)

A Ferroptosis-Related Gene Signature for Predicting the Prognosis and Drug Sensitivity of Head and Neck Squamous Cell Carcinoma
por: Lu, Wei, et al.
Publicado: (2021)

Identification of Immune Subtypes for Predicting the Prognosis of Patients in Head and Neck Squamous Cell Carcinoma
por: Sun, Jing, et al.
Publicado: (2021)

Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma
por: Miao, Ye, et al.
Publicado: (2022)

Identification of immune subtypes and their prognosis and molecular implications in colorectal cancer
por: Sun, Yan, et al.
Publicado: (2022)

Identification of Core Genes Related to Progression and Prognosis of Hepatocellular Carcinoma and Small-Molecule Drug Predication
por: Jiang, Nan, et al.
Publicado: (2021)

Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
por: Yang, Liuqing, et al.
Publicado: (2022)

Poor prognosis, hypomethylation, and immune infiltrates are associated with downregulation of INMT in head and neck squamous cell carcinoma
por: Cui, Kun, et al.
Publicado: (2022)

A pyroptosis expression pattern score predicts prognosis and immune microenvironment of lung squamous cell carcinoma
por: Chen, Wei, et al.
Publicado: (2022)

An original cuproptosis-related genes signature effectively influences the prognosis and immune status of head and neck squamous cell carcinoma
por: Zheng, Xiwang, et al.
Publicado: (2023)

Identification of novel immune-related molecular subtypes and a prognosis model to predict thyroid cancer prognosis and drug resistance
por: Zhang, Wei, et al.
Publicado: (2023)

Identification of the Immune Cell Infiltration Landscape in Hepatocellular Carcinoma to Predict Prognosis and Guide Immunotherapy
por: Yang, Shiyan, et al.
Publicado: (2021)

The expression and methylation of PITX genes is associated with the prognosis of head and neck squamous cell carcinoma
por: Zhao, Yaqiong, et al.
Publicado: (2022)

Identification of Hub Genes Associated With Immune Infiltration and Predict Prognosis in Hepatocellular Carcinoma via Bioinformatics Approaches
por: Chen, Huaping, et al.
Publicado: (2021)

Identification of an Endoplasmic Reticulum Stress-Related Gene Signature to Evaluate the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma
por: Song, Dingli, et al.
Publicado: (2022)

Discovery and Verification of an Immune-Related Gene Pairs Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma
por: He, Jiqiang, et al.
Publicado: (2021)

N1-methyladenosine methylation-related metabolic genes signature and subtypes for predicting prognosis and immune microenvironment in osteosarcoma
por: Wang, Guowei, et al.
Publicado: (2022)

Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
por: Huili, Youlong, et al.
Publicado: (2022)

m7G-related lncRNAs are potential biomarkers for predicting prognosis and immune responses in patients with oral squamous cell carcinoma
por: Wang, Xuefeng, et al.
Publicado: (2022)

A Novel Signature for Predicting Prognosis of Smoking-Related Squamous Cell Carcinoma
por: Chen, Chang, et al.
Publicado: (2021)

Developing a pyroptosis-related gene signature to better predict the prognosis and immune status of patients with head and neck squamous cell carcinoma
por: Liu, Dan, et al.
Publicado: (2023)

Identification of a 5-lncRNA-Based Signature for Immune Characteristics and Prognosis of Lung Squamous Cell Carcinoma and Verification of the Function of lncRNA SPATA41
por: Huan, Sheng, et al.
Publicado: (2022)

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma
por: Gao, Wen, et al.
Publicado: (2022)

Identification of Biomarkers Related to Prognosis of Bladder Transitional Cell Carcinoma
por: Liu, Zhihua, et al.
Publicado: (2021)

Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer
por: Sun, Xiaorui, et al.
Publicado: (2022)

Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage
por: Gan, Xiaoning, et al.
Publicado: (2020)

Cuproptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of early-stage lung adenocarcinoma patients
por: Tang, Yu, et al.
Publicado: (2022)

Integrative Clustering Reveals a Novel Subtype of Soft Tissue Sarcoma With Poor Prognosis
por: Zhu, Zhenhua, et al.
Publicado: (2020)

Development and Validation of a Novel Gene Signature for Predicting the Prognosis by Identifying m5C Modification Subtypes of Cervical Cancer
por: Yu, Jing, et al.
Publicado: (2021)

Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness
por: Zhang, Pei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_evkgpp4i70kajpbhn981o9hlrd